FGF21 and fatty liver disease: Fibroblast growth factor 21 reduced lipid levels and reversed hepatic steatosis, which was associated with FGF21 inhibition of nuclear sterol regulatory element binding protein-1 and the expression of a wide array of genes involved in fatty acid and triglyceride synthesis 15.